# FDA 483 - Consolidated Chemical, Inc - August 02, 2022

Source: https://www.keypedia.com/records/483/consolidated-chemical-inc/052d3a19-8705-4518-a7c2-9a59700db542

> FDA 483 for Consolidated Chemical, Inc on August 02, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Consolidated Chemical, Inc
- Inspection Date: 2022-08-02
- Product Type: drugs
- Office Name: Kansas City District Office
- Summary: An FDA inspection of Consolidated Chemical, Inc. DBA CARETECH Laboratories, Inc. in St. Louis, MO, a drug manufacturer, revealed significant deficiencies across multiple areas. Observations included inadequate procedures for preventing objectionable microorganisms, poor facility maintenance with leaks and exposed wiring, and corroded manufacturing equipment. Additionally, the firm failed to follow its written stability testing program and did not properly record or justify deviations from procedures.

## Related Documents

- [483 - 2008-05-22](https://www.keypedia.com/records/483/consolidated-chemical-inc/b919bc81-7af9-428c-8c06-d822646c51c3)
- [483 - 2008-05-22](https://www.keypedia.com/records/483/consolidated-chemical-inc/845a1298-60d8-4da9-bf3a-030620151818)
- [483 - 2019-08-02](https://www.keypedia.com/records/483/consolidated-chemical-inc/9bee5243-8155-483b-9e16-40ac946ef2ce)

## Related Officers

- [Monica E. Murie](https://www.keypedia.com/people/monica-e-murie/2db840df-d69f-4def-9830-fd461bea5507)
- [Norman K. Starks](https://www.keypedia.com/people/norman-k-starks/4b8776e0-f96e-429c-94d1-40c0369f5378)
- [Matthew M. Schuckmann](https://www.keypedia.com/people/matthew-m-schuckmann/69dd0728-6b5d-41e7-834c-416e25a977dc)

Company: https://www.keypedia.com/companies/consolidated-chemical-inc/f456a0b0-004d-48ed-904f-c2020577ace9

Office: https://www.keypedia.com/offices/kansas-city-district-office/cd397ab1-df4e-46f1-ab1c-0f6db9abcf79